Le Lézard
Classified in: Health, Science and technology
Subjects: TRI, FDA

AstaPure® Astaxanthin Approved by Anvisa Brazil


KIBBUTZ KETURA, Israel, July 26, 2017 /PRNewswire/ --

Algatech (Algatechnologies) Ltd. Received Brazilian Health Regulatory Agency (Anvisa) approval for its all-natural astaxanthin AstaPure® to be used as a food ingredient. Approval was granted thanks to the high quality and purity of this powerful product.

     (Photo: http://mma.prnewswire.com/media/539278/AstaPure_Astaxanthin.jpg )

This approval makes Algatech the first astaxanthin supplier to start marketing its clean-label astaxanthin under the AstaPure brand in Brazil. AstaPure is sourced from the Haematococcus pluvialis microalgae, cultivated in a proprietary fully controlled closed system of glass photo-bioreactors energized by the abundant natural sunlight of the Arava desert.

Brazil has the largest nutritional and supplements market in South America. According to Euromonitor, vitamins and dietary supplements recorded a sales total of US$1.3 billion in 2015 in Brazil, an 11% increase over the previous year. The market shows no signs of slowing down, due to a growing and increasingly health conscious middle-class. Brazil is poised to take the next step in becoming a global powerhouse with exciting potential.

"Brazil holds the leading supplement market in South America, and we strongly believe this approval will create further possibilities in the region," says Gary Brenner, project development manager for Algatech. "Collaborating with our distributor Ayalla, Sao Paulo, we aim to increase our sales and promote our products in cooperation with the leading brand customers in the food, cosmetics and dietary supplements segments."

"Ayalla prides itself in marketing only the highest quality natural nutrients to our Brazilian customers," notes Sandra Ayala de Anselmo, president of marketing for Ayalla. "For two generations, our family has maintained a strong commitment to these standards. Many of our strategic customers already know AstaPure astaxanthin, and we are excited to now realize our investment with the help of Algatech."

"Microalgae is expected to be one of the most important nutrition source of the 21th century. We are proud to be among just a few companies internationally that have cracked the code for commercial-scale production of natural microalgae, at the highest standards," says Hagai Stadler, CEO of Algatech. "We are pleased to bring the Algatech product line to Brazil, and to be able to provide for the first time in Brazil all-natural astaxanthin AstaPure."

Algatech is a leading manufacturer and supplier of innovative algae-based products cultivated using state-of-the-art technologies. The company is located in Israel's Arava desert, between the Dead Sea and the Red Sea, an optimal location for microalgae cultivation, thanks to the stable climate conditions, clean air and water, and intense sunlight throughout the year.

For further information, please contact:

Company contacts
Algatechnologies Ltd.
Ms. Efrat Kat VP, Marketing & Sales
Phone: +972-8-6356425
E-mail: [email protected]
http://www.algatech.com
Twitter: @Algatech98

Media contact
NutriPR
Ms. Liat Simha
Tel: +972-9-9742893
E-mail: [email protected]
Website: http://www.NutriPR.com
Twitter: @LiatSimha


SOURCE Algatech Ltd.


These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: